671 results on '"Krempf, Michel"'
Search Results
2. Burden of cardiovascular disease in a large contemporary cohort of patients with heterozygous familial hypercholesterolemia
3. Untargeted lipidomic analysis of plasma from obese women submitted to combined physical exercise
4. Sphingolipid and Trimethylamine-N-Oxide (TMAO) Levels in Women with Obesity after Combined Physical Training.
5. The Added Value of Coronary Calcium Score in Predicting Cardiovascular Events in Familial Hypercholesterolemia
6. Large-scale screening of lipase acid deficiency in at risk population
7. Efficacy and safety of volanesorsen in patients with multifactorial chylomicronaemia (COMPASS): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
8. SAFEHEART risk-equation and cholesterol-year-score are powerful predictors of cardiovascular events in French patients with familial hypercholesterolemia
9. Efficacy and Safety of Alirocumab in Patients With Autosomal Dominant Hypercholesterolemia Associated With Proprotein Convertase Subtilisin/Kexin Type 9 Gain-of-Function or Apolipoprotein B Loss-of-Function Mutations
10. Pharmacokinetic and pharmacodynamic assessment of alirocumab in patients with familial hypercholesterolemia associated with proprotein convertase subtilisin/kexin type 9 gain-of-function or apolipoprotein B loss-of-function mutations
11. Myalgies et statines : démêler le vrai du faux
12. Cardiovascular contrasted phenotypes in patients with familial hypercholesterolemia: Design and baseline characteristics of the SAFIR study.
13. Residual vascular risk in diabetes – Will the SPPARM alpha concept hold the key?
14. In vivo evidence for transintestinal cholesterol efflux in patients with complete common bile duct obstruction
15. Hepatic deletion of serine palmitoyl transferase 2 impairs ceramide/sphingomyelin balance, bile acids homeostasis and leads to liver damage in mice
16. Hypercholestérolémie familiale peu diagnostiquée, insuffisamment traitée. Enquête auprès de 495 médecins.
17. New rare genetic variants of LMF1 gene identified in severe hypertriglyceridemia
18. Niacin action in the atherogenic mixed dyslipidemia of metabolic syndrome: Insights from metabolic biomarker profiling and network analysis
19. Les déterminants biopsychosociaux de la qualité de vie subjective des patients diabétiques
20. Maternal obesity leads to long-term altered levels of plasma ceramides in the offspring as revealed by a longitudinal lipidomic study in children
21. 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
22. Effect of fasting and feeding on apolipoprotein A-I kinetics in preβ1-HDL, α-HDL, and triglyceride-rich lipoproteins
23. PCSK9 Modulates the Secretion But Not the Cellular Uptake of Lipoprotein(a) Ex Vivo: An Effect Blunted by Alirocumab
24. Evaluation of hypercholesterolemia management in at-risk patients by cardiologists in France: a case vignette-based study
25. Effect of omega-3 fatty acid ethyl esters on postprandial arterial elasticity in patients with familial hypercholesterolemia
26. Effect of Omega-3 Fatty Acid Supplementation on the Postprandial Metabolism of Apolipoprotein(a) in Familial Hypercholesterolemia
27. Maternal Inheritance of Familial Hypercholesterolemia Gene Mutation Predisposes to Coronary Atherosclerosis as Assessed by Calcium Score in Adulthood
28. Plasma ceramide, a real-time predictive marker of pulmonary and hepatic metastases response to stereotactic body radiation therapy combined with irinotecan
29. The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential: A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation
30. Plasma lipidomic analysis reveals strong similarities between lipid fingerprints in human, hamster and mouse compared to other animal species
31. Description des pratiques de l’insulinothérapie basale dans le diabète de type 2 en médecine générale en France : l’étude PRACTISULINE®
32. Burden of cardiovascular disease in a large contemporary cohort of patients with heterozygous familial hypercholesterolemia
33. Plasma Lipidome Analysis by Liquid Chromatography-High Resolution Mass Spectrometry and Ion Mobility of Hypertriglyceridemic Patients on Extended-Release Nicotinic Acid: a Pilot Study
34. Is the Adipose Tissue a Relevant Target for Obesity Treatment?
35. Stable Isotope Kinetic Study of ApoM (Apolipoprotein M)
36. Perinatal Hypercholesterolemia Exacerbates Atherosclerosis Lesions in Offspring by Altering Metabolism of Trimethylamine-N-Oxide and Bile Acids
37. Consequences of blunting the mevalonate pathway in cancer identified by a pluri-omics approach
38. Direct and maternal n-3 long-chain polyunsaturated fatty acid supplementation improved triglyceridemia and glycemia through the regulation of hepatic and muscle sphingolipid synthesis in offspring hamsters fed a high-fat diet
39. Laparoscopic Gastric Banding in Obese Patients with Sleep Apnea: A 3-Year Controlled Study and Follow-up After 10 Years
40. Voltammetry coupled to mass spectrometry in the presence of isotope 18O labeled water for the prediction of oxidative transformation pathways of activated aromatic ethers: Acebutolol
41. Integration of microbiology and infectious disease teaching courses in an interdisciplinary training programme (Master level) centred on the ‘One world, one health’ WHO concept
42. Antibiotic exposure and bacterial resistance in human and veterinary medicine: a problem-based learning topic for Masterʼs students
43. Serum resistance to singlet oxygen in patients with diabetes mellitus in comparison to healthy donors
44. The Added Value of Coronary Calcium Score in Predicting Cardiovascular Events in Familial Hypercholesterolemia
45. Bariatric Surgery Improves the Atherogenic Profile of Circulating Methylarginines in Obese Patients: Results from a Pilot Study
46. Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia not Adequately Controlled with Current Lipid-Lowering Therapy: Design and Rationale of the ODYSSEY FH Studies
47. ODYSSEY FH I and FH II: 78 week results with alirocumab treatment in 735 patients with heterozygous familial hypercholesterolaemia
48. Cardiovascular risk in relation to body mass index and use of evidence-based preventive medications in patients with or at risk of atherothrombosis
49. Acetogenic fibers reduce fasting glucose turnover but not peripheral insulin resistance in metabolic syndrome patients
50. Les charcuteries
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.